Pembrolizumab injection Clinical Trials
5 recruitingDrug
Phase 24Phase 12
Showing 1–5 of 5 trials
Recruiting
Phase 2
Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
Triple Negative Breast Neoplasms
UNICANCER220 enrolled20 locationsNCT05973864
Recruiting
Phase 2
Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)
Renal Cell Carcinoma
University of Alabama at Birmingham100 enrolled1 locationNCT06005818
Recruiting
Phase 1Phase 2
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
MelanomaAdvanced Solid TumorMetastatic Cancer+3 more
CJ Bioscience, Inc.160 enrolled4 locationsNCT05877430
Recruiting
Phase 2
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
Lung AdenocarcinomaImmunotherapyALK Gene Mutation
Hunan Province Tumor Hospital78 enrolled1 locationNCT05266846
Recruiting
Phase 1
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Ovarian CancerMelanoma
Hefei TG ImmunoPharma Co., Ltd.38 enrolled2 locationsNCT05746897